Clinical trial
Metabolomics and Microbiomics in Cardiovascular Diseases
NCT04146701 is registered in ClinicalTrials.gov with Universitätsmedizin Mannheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolomics and Microbiomics in Cardiovascular Diseases
- Lead sponsor
- Universitätsmedizin Mannheim
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 1, 2019
- Completion date
- December 31, 2022
- Enrollment
- 750 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute heart failure, cardiomyopathies, dilated cardiomyopathy, ischemic cardiomyopathy, myocardial infarction, acute, nstemi - non-st segment elevation mi, sepsis, stemi - st elevation myocardial infarction